{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:36:18Z","timestamp":1791804978490,"version":"4.3.4"},"reference-count":264,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s40266-022-00946-x","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T01:02:33Z","timestamp":1656291753000},"page":"523-550","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Pharmacotherapy for Spine-Related Pain in Older Adults"],"prefix":"10.1007","volume":"39","author":[{"given":"Jonathan L.","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0027-9780","authenticated-orcid":false,"given":"Michael D.","family":"Perloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"issue":"10","key":"946_CR1","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s40266-017-0492-4","volume":"34","author":"A Catalano","year":"2017","unstructured":"Catalano A, et al. Pain in osteoporosis: from pathophysiology to therapeutic approach. Drugs Aging. 2017;34(10):755\u201365.","journal-title":"Drugs Aging"},{"key":"946_CR2","doi-asserted-by":"crossref","unstructured":"American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. Pain Med. 2009;10(6):1062\u201383.","DOI":"10.1111\/j.1526-4637.2009.00699.x"},{"key":"946_CR3","doi-asserted-by":"crossref","unstructured":"2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674\u201394.","DOI":"10.1111\/jgs.15767"},{"issue":"Suppl 2","key":"946_CR4","doi-asserted-by":"publisher","first-page":"s192","DOI":"10.1007\/s00586-006-1072-1","volume":"15","author":"O Airaksinen","year":"2006","unstructured":"Airaksinen O, et al. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J. 2006;15(Suppl 2):s192\u2013300.","journal-title":"Eur Spine J"},{"key":"946_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.7326\/0003-4819-147-7-200710020-00008","volume":"147","author":"R Chou","year":"2007","unstructured":"Chou R, Huffman LH. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society\/American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2007;147:505\u201314.","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"946_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ageing\/afs200","volume":"42","author":"A Abdulla","year":"2013","unstructured":"Abdulla A, et al. Guidance on the management of pain in older people. Age Ageing. 2013;42(Suppl 1):1\u201357.","journal-title":"Age Ageing"},{"issue":"8","key":"946_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1055\/s-0031-1296415","volume":"59","author":"A Allegrini","year":"2009","unstructured":"Allegrini A, et al. Efficacy and safety of piroxicam patch versus piroxicam cream in patients with lumbar osteoarthritis. A randomized, placebo-controlled study. Arzneimittelforschung. 2009;59(8):403\u20139. https:\/\/doi.org\/10.1055\/s-0031-1296415.","journal-title":"Arzneimittelforschung"},{"issue":"5","key":"946_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00007632-198706000-00010","volume":"12","author":"E Amlie","year":"1987","unstructured":"Amlie E, Weber H, Holme I. Treatment of acute low-back pain with piroxicam: results of a double-blind placebo-controlled trial. Spine. 1987;12(5):473\u20136.","journal-title":"Spine"},{"issue":"4","key":"946_CR9","first-page":"204","volume":"32","author":"R Babej-D\u00f6lle","year":"1994","unstructured":"Babej-D\u00f6lle R, et al. Parenteral dipyrone versus diclofenac and placebo in patients with acute lumbago or sciatic pain: randomized observer-blind multicenter study. Int J Clin Pharmacol Ther. 1994;32(4):204\u20139.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"2","key":"946_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/ard.41.2.129","volume":"41","author":"H Berry","year":"1982","unstructured":"Berry H, et al. Naproxen sodium, diflunisal, and placebo in the treatment of chronic back pain. Ann Rheum Dis. 1982;41(2):129\u201332.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"946_CR11","first-page":"148","volume":"18","author":"PD Boline","year":"1995","unstructured":"Boline PD, et al. A comparison of the efficacy and tolerability of meloxicam and diclofenac in the treatment of patients with osteoarthritis of the lumbar spine. J Manip Physiol Ther. 1995;18(3):148\u201354.","journal-title":"J Manip Physiol Ther"},{"issue":"8","key":"946_CR12","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/s0149-2918(04)80081-x","volume":"26","author":"TL Coats","year":"2004","unstructured":"Coats TL, et al. Effects of valdecoxib in the treatment of chronic low back pain: results of a randomized, placebo-controlled trial. Clin Ther. 2004;26(8):1249\u201360. https:\/\/doi.org\/10.1016\/s0149-2918(04)80081-x.","journal-title":"Clin Ther"},{"issue":"Suppl 1","key":"946_CR13","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1007\/PL00022375","volume":"50","author":"RL Dreiser","year":"2001","unstructured":"Dreiser RL, et al. Oral meloxicam is effective in acute sciatica: two randomised, double-blind trials versus placebo or diclofenac. Inflamm Res. 2001;50(Suppl 1):S17-23. https:\/\/doi.org\/10.1007\/PL00022375.","journal-title":"Inflamm Res"},{"issue":"9","key":"946_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.5414\/CPP41375","volume":"41","author":"RL Dreiser","year":"2003","unstructured":"Dreiser RL, et al. Relief of acute low back pain with diclofenac-K 12.5 mg tablets: a flexible dose, ibuprofen 200 mg and placebo-controlled clinical trial. Int J Clin Pharmacol Ther. 2003;41(9):375\u201385.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"11","key":"946_CR15","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/S0011-393X(05)80313-3","volume":"55","author":"M Driessens","year":"1994","unstructured":"Driessens M, et al. Efficacy and tolerability of sustained-release ibuprofen in the treatment of patients with chronic back pain. Curr Ther Res. 1994;55(11):1283\u201392.","journal-title":"Curr Ther Res"},{"issue":"1","key":"946_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3810\/psm.2011.02.1857","volume":"39","author":"J Gimbel","year":"2011","unstructured":"Gimbel J, et al. Effectiveness and safety of diclofenac epolamine topical patch 1.3% for the treatment of acute pain due to back strain: an open-label, uncontrolled study. Phys Sportsmed. 2011;39(1):11\u20138.","journal-title":"Phys Sportsmed"},{"issue":"11","key":"946_CR17","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1111\/j.1742-1241.2009.02187.x","volume":"63","author":"WA Herrmann","year":"2009","unstructured":"Herrmann WA, Geertsen MS. Efficacy and safety of lornoxicam compared with placebo and diclofenac in acute sciatica\/lumbo-sciatica: an analysis from a randomised, double-blind, multicentre, parallel-group study. Int J Clin Pract. 2009;63(11):1613\u201321. https:\/\/doi.org\/10.1111\/j.1742-1241.2009.02187.x.","journal-title":"Int J Clin Pract"},{"issue":"7","key":"946_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/BRS.0b013e318275d09c","volume":"38","author":"WJV Heymann","year":"2013","unstructured":"Heymann WJV, et al. Spinal high-velocity low amplitude manipulation in acute nonspecific low back pain: a double-blinded randomized controlled trial in comparison with diclofenac and placebo. Spine. 2013;38(7):540\u20138.","journal-title":"Spine"},{"issue":"1","key":"946_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jpainsymman.2009.05.016","volume":"39","author":"L-F Hsieh","year":"2010","unstructured":"Hsieh L-F, et al. Efficacy and side effects of diclofenac patch in treatment of patients with myofascial pain syndrome of the upper trapezius. J Pain Symptom Manag. 2010;39(1):116\u201325.","journal-title":"J Pain Symptom Manag"},{"issue":"9","key":"946_CR20","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/01.BRS.0000059762.89308.97","volume":"28","author":"N Katz","year":"2003","unstructured":"Katz N, et al. Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials. Spine. 2003;28(9):851\u20138. https:\/\/doi.org\/10.1097\/01.BRS.0000059762.89308.97.","journal-title":"Spine"},{"issue":"7","key":"946_CR21","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.pain.2013.03.006","volume":"154","author":"AJ Kivitz","year":"2013","unstructured":"Kivitz AJ, et al. Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain. Pain. 2013;154(7):1009\u201321. https:\/\/doi.org\/10.1016\/j.pain.2013.03.006 (Epub 2013 Mar 14).","journal-title":"Pain"},{"issue":"6","key":"946_CR22","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1177\/147323000903700615","volume":"37","author":"JB O'Donnell","year":"2009","unstructured":"O\u2019Donnell JB, et al. The effectiveness of a weak opioid medication versus a cyclo-oxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug in treating flare-up of chronic low-back pain: results from two randomized, double-blind, 6-week studies. J Int Med Res. 2009;37(6):1789\u2013802. https:\/\/doi.org\/10.1177\/147323000903700615.","journal-title":"J Int Med Res"},{"issue":"4","key":"946_CR23","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3233\/BMR-160577","volume":"30","author":"JS Petrofsky","year":"2017","unstructured":"Petrofsky JS, et al. Use of low level of continuous heat and Ibuprofen as an adjunct to physical therapy improves pain relief, range of motion and the compliance for home exercise in patients with nonspecific neck pain: a randomized controlled trial. J Back Musculoskelet Rehabil. 2017;30(4):889\u201396. https:\/\/doi.org\/10.3233\/BMR-160577.","journal-title":"J Back Musculoskelet Rehabil"},{"key":"946_CR24","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/1471-2474-14-250","volume":"14","author":"HG Predel","year":"2013","unstructured":"Predel HG, et al. Efficacy and safety of diclofenac diethylamine 1.16% gel in acute neck pain: a randomized, double-blind, placebo-controlled study. BMC Musculoskelet Disord. 2013;14:250. https:\/\/doi.org\/10.1186\/1471-2474-14-250.","journal-title":"BMC Musculoskelet Disord"},{"issue":"6","key":"946_CR25","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00264-016-3154-y","volume":"40","author":"S Sae-Jung","year":"2016","unstructured":"Sae-Jung S, Jirarattanaphochai K. Outcomes of lumbar facet syndrome treated with oral diclofenac or methylprednisolone facet injection: a randomized trial. Int Orthop. 2016;40(6):1091\u20138. https:\/\/doi.org\/10.1007\/s00264-016-3154-y (Epub 2016 Mar 18).","journal-title":"Int Orthop"},{"issue":"8","key":"946_CR26","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.ajem.2016.04.028","volume":"34","author":"M Serinken","year":"2016","unstructured":"Serinken M, et al. Ketoprofen gel improves low back pain in addition to IV dexketoprofen: a randomized placebo-controlled trial. Am J Emerg Med. 2016;34(8):1458\u201361. https:\/\/doi.org\/10.1016\/j.ajem.2016.04.028 (Epub 2016 Apr 22).","journal-title":"Am J Emerg Med"},{"issue":"5","key":"946_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1177\/030006057800600503","volume":"6","author":"W Siegmeth","year":"1978","unstructured":"Siegmeth W, Sieberer W. A comparison of the short-term effects of ibuprofen and diclofenac in spondylosis. J Int Med Res. 1978;6(5):369\u201374.","journal-title":"J Int Med Res"},{"issue":"12","key":"946_CR28","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1185\/030079905X75069","volume":"21","author":"C Zerbini","year":"2005","unstructured":"Zerbini C, et al. Efficacy of etoricoxib 60 mg\/day and diclofenac 150 mg\/day in reduction of pain and disability in patients with chronic low back pain: results of a 4-week, multinational, randomized, double-blind study. Curr Med Res Opin. 2005;21(12):2037\u201349. https:\/\/doi.org\/10.1185\/030079905X75069.","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"946_CR29","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1097\/00007632-200205150-00003","volume":"27","author":"SF Nadler","year":"2002","unstructured":"Nadler SF, et al. Continuous low-level heat wrap therapy provides more efficacy than Ibuprofen and acetaminophen for acute low back pain. Spine. 2002;27(10):1012\u20137.","journal-title":"Spine"},{"issue":"1","key":"946_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3109\/17453676808989446","volume":"39","author":"I Goldie","year":"1968","unstructured":"Goldie I. A clinical trial with indomethacin (indomee(R)) in low back pain and sciatica. Acta Orthop Scand. 1968;39(1):117\u201328. https:\/\/doi.org\/10.3109\/17453676808989446.","journal-title":"Acta Orthop Scand"},{"issue":"11","key":"946_CR31","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1097\/00007632-199309010-00006","volume":"18","author":"H Weber","year":"1993","unstructured":"Weber H, Holme I, Amlie E. The natural course of acute sciatica with nerve root symptoms in a double-blind placebo-controlled trial evaluating the effect of piroxicam. Spine. 1993;18(11):1433\u20138.","journal-title":"Spine"},{"issue":"2","key":"946_CR32","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.106.181424","volume":"115","author":"EM Antman","year":"2007","unstructured":"Antman EM, et al. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007;115(2):1634\u201342.","journal-title":"Circulation"},{"issue":"10","key":"946_CR33","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2165\/11539430-000000000-00000","volume":"27","author":"RL Barkin","year":"2010","unstructured":"Barkin RL, et al. Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult? Drugs Aging. 2010;27(10):775\u201389.","journal-title":"Drugs Aging"},{"issue":"3","key":"946_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/ard.2006.055012","volume":"66","author":"M Boers","year":"2007","unstructured":"Boers M, et al. The rate of NSAID-induced endoscopic ulcers increases linearly but not exponentially with age: a pooled analysis of 12 randomised trials. Ann Rheum Dis. 2007;66(3):417\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"946_CR35","doi-asserted-by":"publisher","first-page":"787","DOI":"10.7326\/0003-4819-115-10-787","volume":"115","author":"SE Gabriel","year":"1991","unstructured":"Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. Ann Intern Med. 1991;115(10):787\u201396.","journal-title":"Ann Intern Med"},{"issue":"6","key":"946_CR36","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/BF03327372","volume":"15","author":"A Pilotto","year":"2003","unstructured":"Pilotto A, et al. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs. Aging Clin Exp Res. 2003;15(6):494\u20139.","journal-title":"Aging Clin Exp Res"},{"issue":"4","key":"946_CR37","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.clinthera.2010.04.009","volume":"32","author":"JM Scheiman","year":"2010","unstructured":"Scheiman JM, Hindley CE. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events. Clin Ther. 2010;32(4):667\u201377.","journal-title":"Clin Ther"},{"issue":"4","key":"946_CR38","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1053\/j.gastro.2008.01.010","volume":"134","author":"LE Targownik","year":"2008","unstructured":"Targownik LE, et al. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs. Gastroenterology. 2008;134(4):937\u201344.","journal-title":"Gastroenterology"},{"issue":"7","key":"946_CR39","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1185\/03007995.2011.581274","volume":"27","author":"SR Mallen","year":"2011","unstructured":"Mallen SR, Essex MN, Zhang R. Gastrointestinal tolerability of NSAIDs in elderly patients: a pooled analysis of 21 randomized clinical trials with celecoxib and nonselective NSAIDs. Curr Med Res Opin. 2011;27(7):1359\u201366.","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"946_CR40","doi-asserted-by":"publisher","first-page":"E685","DOI":"10.36076\/ppj.2013\/16\/E685","volume":"16","author":"JW Chung","year":"2013","unstructured":"Chung JW, Zeng Y, Wong TK. Drug therapy for the treatment of chronic nonspecific low back pain: systematic review and meta-analysis. Pain Phys. 2013;16(6):E685-704.","journal-title":"Pain Phys"},{"issue":"12","key":"946_CR41","first-page":"1461","volume":"15","author":"M Musu","year":"2011","unstructured":"Musu M, et al. Acute nephrotoxicity of NSAID from the foetus to the adult. Eur Rev Med Pharmacol Sci. 2011;15(12):1461\u201372.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"946_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2165\/00002512-199812010-00003","volume":"12","author":"AG Johnson","year":"2012","unstructured":"Johnson AG. NSAIDs and blood pressure. Drugs Aging. 2012;12:17\u201327.","journal-title":"Drugs Aging"},{"key":"946_CR43","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00228-014-1734-6","volume":"70","author":"M Wehling","year":"2014","unstructured":"Wehling M. Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects. Eur J Clin Pharm. 2014;70:1159\u201372.","journal-title":"Eur J Clin Pharm"},{"issue":"4","key":"946_CR44","first-page":"297","volume":"79","author":"M Shatsky","year":"2009","unstructured":"Shatsky M. Evidence for the use of intramuscular injections in outpatient practice. Am Fam Phys. 2009;79(4):297\u2013300.","journal-title":"Am Fam Phys"},{"issue":"9954","key":"946_CR45","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/S0140-6736(14)60805-9","volume":"384","author":"CM Williams","year":"2014","unstructured":"Williams CM, et al. Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial. Lancet. 2014;384(9954):1586\u201396.","journal-title":"Lancet"},{"issue":"3","key":"946_CR46","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jos.2018.02.007","volume":"23","author":"K Miki","year":"2018","unstructured":"Miki K, et al. Randomized open-label [corrected] non-inferiority trial of acetaminophen or loxoprofen for patients with acute low back pain. J Orthop Sci. 2018;23(3):483\u20137. https:\/\/doi.org\/10.1016\/j.jos.2018.02.007 (Epub 2018 Mar 2).","journal-title":"J Orthop Sci"},{"issue":"1","key":"946_CR47","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/rheumatology\/kel195","volume":"46","author":"MJ Yelland","year":"2007","unstructured":"Yelland MJ, et al. Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials. Rheumatology (Oxford). 2007;46(1):135\u201340. https:\/\/doi.org\/10.1093\/rheumatology\/kel195 (Epub 2006 Jun 15).","journal-title":"Rheumatology (Oxford)"},{"issue":"707","key":"946_CR48","first-page":"312","volume":"95","author":"RF Hickey","year":"1982","unstructured":"Hickey RF. Chronic low back pain: a comparison of diflunisal with paracetamol. N Z Med J. 1982;95(707):312\u20134.","journal-title":"N Z Med J"},{"issue":"6","key":"946_CR49","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/acem.12956","volume":"23","author":"M Serinken","year":"2016","unstructured":"Serinken M, et al. Comparison of intravenous morphine versus paracetamol in sciatica: a randomized placebo controlled trial. Acad Emerg Med. 2016;23(6):674\u20138. https:\/\/doi.org\/10.1111\/acem.12956 (Epub 2016 May 11).","journal-title":"Acad Emerg Med"},{"issue":"1","key":"946_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12906-018-2087-y","volume":"18","author":"H Oka","year":"2018","unstructured":"Oka H, et al. A comparative study of three conservative treatments in patients with lumbar spinal stenosis: lumbar spinal stenosis with acupuncture and physical therapy study (LAP study). BMC Complement Altern Med. 2018;18(1):19. https:\/\/doi.org\/10.1186\/s12906-018-2087-y.","journal-title":"BMC Complement Altern Med"},{"key":"946_CR51","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s40266-018-0559-x","volume":"35","author":"P Mian","year":"2018","unstructured":"Mian P, et al. Paracetamol in older people: towards evidence-based dosing? Drugs Aging. 2018;35:603\u201324.","journal-title":"Drugs Aging"},{"key":"946_CR52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40266-019-00658-9","volume":"36","author":"PG Conaghan","year":"2019","unstructured":"Conaghan PG, et al. Safety of paracetamol in osteoarthritis: what does the literature say? Drugs Aging. 2019;36:7\u201314.","journal-title":"Drugs Aging"},{"issue":"1","key":"946_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rdc.2006.12.001","volume":"33","author":"RL Barkin","year":"2007","unstructured":"Barkin RL, Barkin SJ, Barkin DS. Pharmacotherapeutic management of pain with a focus directed at the geriatric patient. Rheum Dis Clin N Am. 2007;33(1):1\u201331.","journal-title":"Rheum Dis Clin N Am"},{"issue":"3","key":"946_CR54","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1017\/s0317167100001360","volume":"28","author":"PJ Dyck","year":"2001","unstructured":"Dyck PJ, Norell JE, Dyck PJ. Methylprednisolone may improve lumbosacral radiculoplexus neuropathy. Can J Neurol Sci. 2001;28(3):224\u20137. https:\/\/doi.org\/10.1017\/s0317167100001360.","journal-title":"Can J Neurol Sci"},{"issue":"4","key":"946_CR55","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/01.brs.0000199917.04145.80","volume":"31","author":"A Finckh","year":"2006","unstructured":"Finckh A, et al. Short-term efficacy of intravenous pulse glucocorticoids in acute discogenic sciatica. A randomized controlled trial. Spine. 2006;31(4):377\u201381.","journal-title":"Spine"},{"issue":"7","key":"946_CR56","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/emermed-2013-203490","volume":"32","author":"R Balakrishnamoorthy","year":"2015","unstructured":"Balakrishnamoorthy R, et al. Does a single dose of intravenous dexamethasone reduce Symptoms in Emergency department patients with low Back pain and RAdiculopathy (SEBRA)? A double-blind randomised controlled trial. Emerg Med J. 2015;32(7):525\u201330.","journal-title":"Emerg Med J"},{"issue":"1","key":"946_CR57","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jemermed.2014.02.010","volume":"47","author":"B Eskin","year":"2014","unstructured":"Eskin B, et al. Prednisone for emergency department low back pain: a randomized controlled trial. J Emerg Med. 2014;47(1):65\u201370.","journal-title":"J Emerg Med"},{"key":"946_CR58","first-page":"S43","volume":"18","author":"M Ghasemi","year":"2013","unstructured":"Ghasemi M, et al. Oral prednisolone in the treatment of cervical radiculopathy: a randomized placebo controlled trial. J Res Med Sci. 2013;18:S43\u20136.","journal-title":"J Res Med Sci"},{"issue":"13","key":"946_CR59","first-page":"1","volume":"13","author":"LCL Rodrigues","year":"2014","unstructured":"Rodrigues LCL, Natour J. A double-blind, randomized controlled, prospective trial assessing the effectiveness of oral corticoids in the treatment of symptomatic lumbar canal stenosis. J Negat Results BioMed. 2014;13(13):1\u20136.","journal-title":"J Negat Results BioMed"},{"issue":"4","key":"946_CR60","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/MRR.0000000000000432","volume":"43","author":"HA Aghdam","year":"2020","unstructured":"Aghdam HA, et al. A short-term oral corticosteroid for refractory lumbar spinal stenosis: a double-blinded randomized placebo-controlled clinical trial. Int J Rehabil Res. 2020;43(4):342\u20136.","journal-title":"Int J Rehabil Res"},{"issue":"19","key":"946_CR61","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1001\/jama.2015.4468","volume":"313","author":"H Goldberg","year":"2015","unstructured":"Goldberg H, et al. Oral steroids for acute radiculopathy due to a herniated lumbar disk: a randomized clinical trial. JAMA. 2015;313(19):1915\u201323. https:\/\/doi.org\/10.1001\/jama.2015.4468.","journal-title":"JAMA"},{"issue":"3","key":"946_CR62","doi-asserted-by":"publisher","first-page":"262","DOI":"10.4055\/cios.2016.8.3.262","volume":"8","author":"S Ko","year":"2016","unstructured":"Ko S, et al. The effectiveness of oral corticosteroids for management of lumbar radiating pain: randomized, controlled trial study. Clin Orthop Surg. 2016;8(3):262\u20137. https:\/\/doi.org\/10.4055\/cios.2016.8.3.262 (Epub 2016 Aug 10).","journal-title":"Clin Orthop Surg"},{"issue":"4","key":"946_CR63","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","volume":"15","author":"M Oray","year":"2016","unstructured":"Oray M, et al. Long-term side effects of glucocorticoids. Expert Opin Drug Saf. 2016;15(4):457\u201365.","journal-title":"Expert Opin Drug Saf"},{"issue":"30","key":"946_CR64","first-page":"1","volume":"9","author":"D Liu","year":"2013","unstructured":"Liu D, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(30):1\u201325.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"946_CR65","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1136\/ard.2009.124958","volume":"69","author":"MCVD Goes","year":"2010","unstructured":"Goes MCVD, et al. Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice. Ann Rheum Dis. 2010;69:1913\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"946_CR66","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/2049463720912496","volume":"14","author":"M Chincholkar","year":"2020","unstructured":"Chincholkar M. Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice. Br J Pain. 2020;14(2):104\u201314.","journal-title":"Br J Pain"},{"issue":"6","key":"946_CR67","volume":"6","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen PJ, et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;6(6): CD007938.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"946_CR68","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1163\/156856900750229825","volume":"12","author":"GJ McCleane","year":"2000","unstructured":"McCleane GJ. Gabapentin reduces chronic benign nociceptive pain: a double-blind, placebo-controlled cross-over study. Pain Clin. 2000;12(2):81\u20135.","journal-title":"Pain Clin"},{"issue":"3","key":"946_CR69","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1163\/156856903767650718","volume":"15","author":"K Yildirim","year":"2003","unstructured":"Yildirim K, et al. The effectiveness of gabapentin in patients with chronic radiculopathy. Pain Clin. 2003;15(3):213\u20138.","journal-title":"Pain Clin"},{"issue":"2","key":"946_CR70","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1163\/156856901753420945","volume":"13","author":"GJ McCleane","year":"2001","unstructured":"McCleane GJ. Does gabapentin have an analgesic effect on background, movement and referred pain? A randomised, double-blind, placebo controlled study. Pain Clin. 2001;13(2):103\u20137.","journal-title":"Pain Clin"},{"issue":"7","key":"946_CR71","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1097\/j.pain.0000000000000554","volume":"157","author":"JH Atkinson","year":"2016","unstructured":"Atkinson JH, et al. A randomized controlled trial of gabapentin for chronic low back pain with and without a radiating component. Pain. 2016;157(7):1499\u2013507. https:\/\/doi.org\/10.1097\/j.pain.0000000000000554.","journal-title":"Pain"},{"key":"946_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2010.04.013","author":"R Baron","year":"2010","unstructured":"Baron R, et al. The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy. Pain. 2010. https:\/\/doi.org\/10.1016\/j.pain.2010.04.013.","journal-title":"Pain"},{"issue":"3","key":"946_CR73","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/WNL.0000000000001168","volume":"84","author":"JD Markman","year":"2015","unstructured":"Markman JD, et al. Double-blind, randomized, controlled, crossover trial of pregabalin for neurogenic claudication. Neurology. 2015;84(3):265\u201372. https:\/\/doi.org\/10.1212\/WNL.0000000000001168 (Epub 2014 Dec 10).","journal-title":"Neurology"},{"issue":"12","key":"946_CR74","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMoa1614292","volume":"376","author":"S Mathieson","year":"2017","unstructured":"Mathieson S, et al. Trial of pregabalin for acute and chronic sciatica. N Engl J Med. 2017;376(12):1111\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1614292.","journal-title":"N Engl J Med"},{"issue":"9","key":"946_CR75","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1097\/01.brs.0000261029.29170.e6","volume":"32","author":"A Yaksi","year":"2007","unstructured":"Yaksi A, Ozg\u00f6nenel L, Ozg\u00f6nenel B. The efficiency of gabapentin therapy in patients with lumbar spinal stenosis. Spine (Phila Pa, 2007). 2007;32(9):939\u201342. https:\/\/doi.org\/10.1097\/01.brs.0000261029.29170.e6.","journal-title":"Spine (Phila Pa, 2007)"},{"issue":"7","key":"946_CR76","first-page":"767","volume":"97","author":"S Kantito","year":"2014","unstructured":"Kantito S, et al. Comparison of the effectiveness between generic and original form of gabapentin for pain relief in suspected neuropathic component of low back pain. J Med Assoc Thai. 2014;97(7):767\u201375.","journal-title":"J Med Assoc Thai"},{"key":"946_CR77","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1748","volume":"350","author":"SP Cohen","year":"2015","unstructured":"Cohen SP, et al. Epidural steroid injections compared with gabapentin for lumbosacral radicular pain: multicenter randomized double blind comparative efficacy study. BMJ. 2015;350: h1748.","journal-title":"BMJ"},{"key":"946_CR78","doi-asserted-by":"publisher","first-page":"4905013","DOI":"10.1155\/2019\/4905013","volume":"2019","author":"CJ Hwang","year":"2019","unstructured":"Hwang CJ, et al. Gabapentin versus transdermal fentanyl matrix for the alleviation of chronic neuropathic pain of radicular origin: a randomized blind multicentered parallel-group noninferiority trial. Pain Res Manag. 2019;2019:4905013.","journal-title":"Pain Res Manag"},{"issue":"11","key":"946_CR79","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1093\/pm\/pnw052","volume":"17","author":"KL Robertson","year":"2016","unstructured":"Robertson KL, Marshman LA. Gabapentin superadded to a pre-existent regime containing amytriptyline for chronic sciatica. Pain Med. 2016;17(11):2095\u20139. https:\/\/doi.org\/10.1093\/pm\/pnw052 (Epub 2016 Apr 3).","journal-title":"Pain Med"},{"issue":"2","key":"946_CR80","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4184\/asj.2015.9.2.254","volume":"9","author":"Y Sakai","year":"2015","unstructured":"Sakai Y, et al. Neuropathic pain in elderly patients with chronic low back painand effects of pregabalin: a preliminary study. Asian Spine J. 2015;9(2):254\u201362.","journal-title":"Asian Spine J"},{"key":"946_CR81","doi-asserted-by":"publisher","first-page":"5079675","DOI":"10.1155\/2016\/5079675","volume":"2016","author":"S Orita","year":"2016","unstructured":"Orita S, et al. Pregabalin for refractory radicular leg pain due to lumbar spinal stenosis: a preliminary prospective study. Pain Res Manag. 2016;2016:5079675.","journal-title":"Pain Res Manag"},{"issue":"8","key":"946_CR82","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00296-009-1086-1","volume":"30","author":"MT Salda\u00f1a","year":"2010","unstructured":"Salda\u00f1a MT, et al. Patient-reported-outcomes in subjects with painful lumbar or cervical radiculopathy treated with pregabalin: evidence from medical practice in primary care settings. Rheumatol Int. 2010;30(8):1005\u201315. https:\/\/doi.org\/10.1007\/s00296-009-1086-1 (Epub 2009 Oct 2).","journal-title":"Rheumatol Int"},{"issue":"4","key":"946_CR83","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10195-009-0077-z","volume":"10","author":"CL Roman\u00f2","year":"2009","unstructured":"Roman\u00f2 CL, et al. Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain. J Orthop Traumatol. 2009;10(4):185\u201391. https:\/\/doi.org\/10.1007\/s10195-009-0077-z (Epub 2009 Nov 18).","journal-title":"J Orthop Traumatol"},{"issue":"1\u20132","key":"946_CR84","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jns.2014.05.002","volume":"342","author":"J Kalita","year":"2014","unstructured":"Kalita J, et al. An open labeled randomized controlled trial of pregabalin versus amitriptyline in chronic low backache. J Neurol Sci. 2014;342(1\u20132):127\u201332. https:\/\/doi.org\/10.1016\/j.jns.2014.05.002 (Epub 2014 May 10).","journal-title":"J Neurol Sci"},{"issue":"6","key":"946_CR85","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.spinee.2016.02.049","volume":"16","author":"HJ Kim","year":"2016","unstructured":"Kim HJ, et al. Comparative study of the efficacy of limaprost and pregabalin as single agents and in combination for the treatment of lumbar spinal stenosis: a prospective, double-blind, randomized controlled non-inferiority trial. Spine J. 2016;16(6):756\u201363. https:\/\/doi.org\/10.1016\/j.spinee.2016.02.049 (Epub 2016 Mar 29).","journal-title":"Spine J"},{"issue":"2","key":"946_CR86","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5387\/fms.2018-07","volume":"64","author":"A Onda","year":"2018","unstructured":"Onda A, Kimura M. Comparisons between the efficacy of limaprost alfadex and pregabalin in cervical spondylotic radiculopathy: design of a randomized controlled trial. Fukushima J Med Sci. 2018;64(2):73\u201381. https:\/\/doi.org\/10.5387\/fms.2018-07 (Epub 2018 Jul 14).","journal-title":"Fukushima J Med Sci"},{"issue":"1","key":"946_CR87","doi-asserted-by":"publisher","first-page":"8120","DOI":"10.1038\/s41598-020-65108-8","volume":"10","author":"JM Jung","year":"2020","unstructured":"Jung JM, et al. Comparison of the use of opioids only and pregabalin add-on for the treatment of neuropathic pain in cervical myelopathy patients: a pilot trial. Sci Rep. 2020;10(1):8120. https:\/\/doi.org\/10.1038\/s41598-020-65108-8.","journal-title":"Sci Rep"},{"issue":"1","key":"946_CR88","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1001\/jamaneurol.2018.3077","volume":"76","author":"K Robertson","year":"2019","unstructured":"Robertson K, et al. Effect of gabapentin vs pregabalin on pain intensity in adults with chronic sciatica: a randomized clinical trial. JAMA Neurol. 2019;76(1):28\u201334. https:\/\/doi.org\/10.1001\/jamaneurol.2018.3077.","journal-title":"JAMA Neurol"},{"issue":"2","key":"946_CR89","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00776-013-0529-4","volume":"19","author":"T Tetsunaga","year":"2014","unstructured":"Tetsunaga T, et al. Outcomes of pregabalin in lumbar-disease patients with depression. J Orthop Sci. 2014;19(2):229\u201334.","journal-title":"J Orthop Sci"},{"issue":"8","key":"946_CR90","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2165\/11536280-000000000-00000","volume":"30","author":"C Morera-Dom\u00ednguez","year":"2010","unstructured":"Morera-Dom\u00ednguez C, et al. A cost-consequence analysis of pregabalin versus usual care in the symptomatic treatment of refractory low back pain. Clin Drug Investig. 2010;30(8):517\u201331.","journal-title":"Clin Drug Investig"},{"issue":"6","key":"946_CR91","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s00586-015-3812-6","volume":"24","author":"Y Sakai","year":"2015","unstructured":"Sakai Y, et al. Pharmacological management of chronic low back pain in older patients: a randomized controlled trial of the effect of pregabalin and opioid administration. Eur Spine J. 2015;24(6):1309\u201317. https:\/\/doi.org\/10.1007\/s00586-015-3812-6 (Epub 2015 Feb 15).","journal-title":"Eur Spine J"},{"issue":"85","key":"946_CR92","first-page":"1","volume":"11","author":"D Semel","year":"2010","unstructured":"Semel D, et al. Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies. BMC Fam Pract. 2010;11(85):1\u20132.","journal-title":"BMC Fam Pract"},{"key":"946_CR93","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/JPR.S130942","volume":"10","author":"M Raouf","year":"2017","unstructured":"Raouf M, et al. Rational dosing of gabapentin and pregabalin in chronic kidney disease. J Pain Res. 2017;10:275\u20138.","journal-title":"J Pain Res"},{"issue":"2","key":"946_CR94","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s40122-020-00189-x","volume":"9","author":"H McAnally","year":"2020","unstructured":"McAnally H, Bonnet U, Kaye AD. Gabapentinoid benefit and risk stratification: mechanisms over myth. Pain Ther. 2020;9(2):441\u201352.","journal-title":"Pain Ther"},{"issue":"2","key":"946_CR95","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jpainsymman.2004.05.002","volume":"28","author":"R Chou","year":"2004","unstructured":"Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manag. 2004;28(2):140\u201375.","journal-title":"J Pain Symptom Manag"},{"key":"946_CR96","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1446","volume":"374","author":"AG Cashin","year":"2021","unstructured":"Cashin AG, et al. Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis. BMJ. 2021;374: n1446.","journal-title":"BMJ"},{"issue":"2","key":"946_CR97","first-page":"58","volume":"59","author":"JV Basmajian","year":"1978","unstructured":"Basmajian JV. Cyclobenzaprine hydrochloride effect on skeletal muscle spasm in the lumbar region and neck: two double-blind controlled clinical and laboratory studies. Arch Phys Med Rehabil. 1978;59(2):58\u201363.","journal-title":"Arch Phys Med Rehabil"},{"issue":"2","key":"946_CR98","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/030006058801600202","volume":"16","author":"H Berry","year":"1988","unstructured":"Berry H, Hutchinson DR. Tizanidine and ibuprofen in acute low-back pain: results of a double-blind multicentre study in general practice. J Int Med Res. 1988;16(2):83\u201391.","journal-title":"J Int Med Res"},{"issue":"2","key":"946_CR99","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/030006058801600201","volume":"16","author":"H Berry","year":"1988","unstructured":"Berry H, Hutchinson DR. A multicentre placebo-controlled study in general practice to evaluate the efficacy and safety of tizanidine in acute low-back pain. J Int Med Res. 1988;16(2):75\u201382. https:\/\/doi.org\/10.1177\/030006058801600201.","journal-title":"J Int Med Res"},{"issue":"2","key":"946_CR100","first-page":"125","volume":"12","author":"DG Borenstein","year":"1990","unstructured":"Borenstein DG, Lacks S, Wiesel SW. Cyclobenzaprine and naproxen versus naproxen alone in the treatment of acute low back pain and muscle spasm. Clin Ther. 1990;12(2):125\u201331.","journal-title":"Clin Ther"},{"issue":"2","key":"946_CR101","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/00002508-198806000-00004","volume":"4","author":"R Casale","year":"1988","unstructured":"Casale R. Acute low back pain: symptomatic treatment with a muscle relaxant drug. Clin J Pain. 1988;4(2):81\u20138.","journal-title":"Clin J Pain"},{"issue":"9","key":"946_CR102","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1185\/030079905X61938","volume":"21","author":"MK Childers","year":"2005","unstructured":"Childers MK, et al. Low-dose cyclobenzaprine versus combination therapy with ibuprofen for acute neck or back pain with muscle spasm: a randomized trial. Curr Med Res Opin. 2005;21(9):1485\u201393.","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"946_CR103","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/00007632-198505000-00010","volume":"10","author":"F Dapas","year":"1985","unstructured":"Dapas F, et al. Baclofen for the treatment of acute low-back syndrome. A double-blind comparison with placebo. Spine (Phila Pa, 1985). 1985;10(4):345\u20139. https:\/\/doi.org\/10.1097\/00007632-198505000-00010.","journal-title":"Spine (Phila Pa, 1985)."},{"issue":"6","key":"946_CR104","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1001\/jama.1966.03100060119031","volume":"195","author":"S Diamond","year":"1966","unstructured":"Diamond S. Double-blind study of metaxalone: use as skeletal-muscle relaxant. JAMA. 1966;195(6):479\u201380.","journal-title":"JAMA"},{"issue":"3","key":"946_CR105","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.annemergmed.2017.09.031","volume":"71","author":"BW Friedman","year":"2018","unstructured":"Friedman BW, et al. A randomized, double-blind, placebo-controlled trial of naproxen with or without orphenadrine or methocarbamol for acute low back pain. Ann Emerg Med. 2018;71(3):348\u201356.","journal-title":"Ann Emerg Med"},{"issue":"4","key":"946_CR106","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.annemergmed.2019.02.017","volume":"74","author":"BW Friedman","year":"2019","unstructured":"Friedman BW, et al. A randomized, placebo-controlled trial of ibuprofen plus metaxalone, tizanidine, or baclofen for acute low back pain. Ann Emerg Med. 2019;74(4):512\u201320.","journal-title":"Ann Emerg Med"},{"key":"946_CR107","doi-asserted-by":"crossref","unstructured":"Group STA-PS. Efficacy and gastroprotective effects of tizanidine plus diclofenac versus placebo plus diclofenac in patients with painful muscle spasms. Curr Ther Res. 1998;59(1):13\u201322.","DOI":"10.1016\/S0011-393X(98)85019-4"},{"issue":"2","key":"946_CR108","first-page":"7","volume":"117","author":"TH Hindle","year":"1972","unstructured":"Hindle TH. Comparison of carisoprodol, butabarbital, and placebo in treatment of the low back syndrome. Calif Med. 1972;117(2):7\u201311.","journal-title":"Calif Med"},{"issue":"8","key":"946_CR109","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1185\/03007998309109793","volume":"8","author":"HO H\u00f8ivik","year":"1983","unstructured":"H\u00f8ivik HO, Moe N. Effect of a combination of orphenadrine\/paracetamol tablets (\u2018Norgesic\u2019) on myalgia: a double-blind comparison with placebo in general practice. Curr Med Res Opin. 1983;8(8):531\u20135.","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"946_CR110","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.1978.03290110049018","volume":"240","author":"BR Brown Jr","year":"1978","unstructured":"Brown Jr BR, Womble J. Cyclobenzaprine in intractable pain syndromes with muscle spasm. JAMA. 1978;240(11):1151\u20132.","journal-title":"JAMA"},{"issue":"7","key":"946_CR111","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/j.1742-1241.2004.00454.x","volume":"59","author":"A Ketenci","year":"2005","unstructured":"Ketenci A, Ozcan E, Karamursel S. Assessment of efficacy and psychomotor performances of thiocolchicoside and tizanidine in patients with acute low back pain. Int J Clin Pract. 2005;59(7):764\u201370.","journal-title":"Int J Clin Pract"},{"issue":"1","key":"946_CR112","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1017\/S1481803500012008","volume":"12","author":"SM Khwaja","year":"2010","unstructured":"Khwaja SM, Minnerop M, Singer AJ. Comparison of ibuprofen, cyclobenzaprine or both in patients with acute cervical strain: a randomized controlled trial. CJEM. 2010;12(1):39\u201344.","journal-title":"CJEM"},{"issue":"5","key":"946_CR113","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1185\/03007990902851753","volume":"25","author":"GA Malanga","year":"2009","unstructured":"Malanga GA, et al. Cyclobenzaprine ER for muscle spasm associated with low back and neck pain: two randomized, double-blind, placebo-controlled studies of identical design. Curr Med Res Opin. 2009;25(5):1179\u201396. https:\/\/doi.org\/10.1185\/03007990902851753.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"946_CR114","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/030006058301100109","volume":"11","author":"BW McGuinness","year":"1983","unstructured":"McGuinness BW. A double-blind comparison in general practice of a combination tablet containing orphenadrine citrate and paracetamol ('Norgesic\u2019) with paracetamol alone. J Int Med Res. 1983;11(1):42\u20135.","journal-title":"J Int Med Res"},{"issue":"12","key":"946_CR115","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1007\/s00586-009-1019-4","volume":"18","author":"A Pareek","year":"2009","unstructured":"Pareek A, et al. Aceclofenac-tizanidine in the treatment of acute low back pain: a double-blind, double-dummy, randomized, multicentric, comparative study against aceclofenac alone. Eur Spine J. 2009;18(12):1836\u201342. https:\/\/doi.org\/10.1007\/s00586-009-1019-4 (Epub 2009 May 7).","journal-title":"Eur Spine J"},{"issue":"2","key":"946_CR116","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1185\/030079908x261014","volume":"24","author":"L Ralph","year":"2008","unstructured":"Ralph L, et al. Double-blind, placebo-controlled trial of carisoprodol 250-mg tablets in the treatment of acute lower-back spasm. Curr Med Res Opin. 2008;24(2):551\u20138. https:\/\/doi.org\/10.1185\/030079908x261014.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"946_CR117","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1185\/03007990903382428","volume":"26","author":"GT Serfer","year":"2010","unstructured":"Serfer GT, Wheeler WJ, Sacks HJ. Randomized, double-blind trial of carisoprodol 250 mg compared with placebo and carisoprodol 350 mg for the treatment of low back spasm. Curr Med Res Opin. 2010;26(1):91\u20139.","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"946_CR118","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1067\/mem.2003.188","volume":"41","author":"MA Turturro","year":"2003","unstructured":"Turturro MA, Frater CR, D\u2019Amico FJ. Cyclobenzaprine with ibuprofen versus ibuprofen alone in acute myofascial strain: a randomized, double-blind clinical trial. Ann Emerg Med. 2003;41(6):818\u201326. https:\/\/doi.org\/10.1067\/mem.2003.188.","journal-title":"Ann Emerg Med"},{"issue":"2","key":"946_CR119","first-page":"85","volume":"7","author":"EJ Valtonen","year":"1975","unstructured":"Valtonen EJ. A controlled clinical trial of chlormezanone, orphenadrine, orphenadrine\/paracetamol and placebo in the treatment of painful skeletal muscle spasms. Ann Clin Res. 1975;7(2):85\u20138.","journal-title":"Ann Clin Res"},{"issue":"6","key":"946_CR120","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1185\/03007997509114791","volume":"3","author":"EJ Valtonen","year":"1975","unstructured":"Valtonen EJ. A double-blind trial of methocarbamol versus placebo in painful muscle spasm. Curr Med Res Opin. 1975;3(6):382\u20135.","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"946_CR121","first-page":"677","volume":"6","author":"K Fathie","year":"1964","unstructured":"Fathie K. A second look at a skeletal muscle relaxant: a double-blind study of metaxalone. Curr Ther Res Clin Exp. 1964;6(11):677\u201383.","journal-title":"Curr Ther Res Clin Exp"},{"key":"946_CR122","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40122-019-0112-6","volume":"8","author":"HD Patel","year":"2019","unstructured":"Patel HD, et al. Efficacy and safety of combination of NSAIDs and muscle relaxants in the management of acute low back pain. Pain Ther. 2019;8:121\u201332.","journal-title":"Pain Ther"},{"issue":"7\u20138","key":"946_CR123","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1345\/aph.1R735","volume":"47","author":"MM Spence","year":"2013","unstructured":"Spence MM, et al. Risk of injury associated with skeletal muscle relaxant use in older adults. Ann Pharmacother. 2013;47(7\u20138):993\u20138.","journal-title":"Ann Pharmacother"},{"issue":"6","key":"946_CR124","first-page":"427","volume":"39","author":"C Witenko","year":"2014","unstructured":"Witenko C, et al. Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain. Pharm Ther. 2014;39(6):427\u201335.","journal-title":"Pharm Ther"},{"issue":"1","key":"946_CR125","first-page":"25","volume":"45","author":"C Trueman","year":"2020","unstructured":"Trueman C, et al. Inappropriate use of skeletal muscle relaxants in geriatric patients. Geriatrics. 2020;45(1):25\u20139.","journal-title":"Geriatrics"},{"issue":"2","key":"946_CR126","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1053\/j.ajkd.2017.07.005","volume":"71","author":"E Wolf","year":"2018","unstructured":"Wolf E, et al. Baclofen toxicity in kidney disease. Am J Kidney Dis. 2018;71(2):275\u201380.","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"946_CR127","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1007\/s00586-018-5673-2","volume":"27","author":"CB Oliveira","year":"2018","unstructured":"Oliveira CB, et al. Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J. 2018;27(11):2791\u2013803.","journal-title":"Eur Spine J"},{"key":"946_CR128","unstructured":"National Institute for Health and Care Excellence. Neuropathic pain in adults: pharmacological management in non-specialist settings. NICE Clin Guidel. 2020;173."},{"issue":"Suppl 6","key":"946_CR129","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00586-017-5433-8","volume":"27","author":"R Chou","year":"2018","unstructured":"Chou R, et al. The Global Spine Care Initiative: applying evidence-based guidelines on the non-invasive management of back and neck pain to low- and middle-income communities. Eur Spine J. 2018;27(Suppl 6):851\u201360.","journal-title":"Eur Spine J"},{"key":"946_CR130","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4825","volume":"372","author":"GE Ferreira","year":"2021","unstructured":"Ferreira GE, et al. Efficacy and safety of antidepressants for the treatment of back pain and osteoarthritis: systematic review and meta-analysis. BMJ. 2021;372: m4825.","journal-title":"BMJ"},{"issue":"5","key":"946_CR131","first-page":"841","volume":"14","author":"J Alcoff","year":"1982","unstructured":"Alcoff J, et al. Controlled trial of imipramine for chronic low back pain. J Fam Pract. 1982;14(5):841\u20136.","journal-title":"J Fam Pract"},{"issue":"3","key":"946_CR132","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0304-3959(98)00064-5","volume":"76","author":"HJ Atkinson","year":"1998","unstructured":"Atkinson HJ, et al. A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain. 1998;76(3):287\u201396. https:\/\/doi.org\/10.1016\/S0304-3959(98)00064-5.","journal-title":"Pain"},{"issue":"6 Pt 1","key":"946_CR133","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1097\/01.ju.0000145511.56476.00","volume":"172","author":"JH Atkinson","year":"2004","unstructured":"Atkinson JH, et al. Efficacy of noradrenergic and serotonergic antidepressants in chronic back pain: a preliminary concentration-controlled trial. J Urol. 2004;172(6 Pt 1):2203\u20137. https:\/\/doi.org\/10.1097\/01.ju.0000145511.56476.00.","journal-title":"J Urol"},{"issue":"1","key":"946_CR134","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jpsychires.2004.04.011","volume":"39","author":"SK Brannan","year":"2005","unstructured":"Brannan SK, et al. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder. J Psychiatr Res. 2005;39(1):43\u201353.","journal-title":"J Psychiatr Res"},{"issue":"6","key":"946_CR135","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0022-3956(02)00060-2","volume":"36","author":"MJ Detke","year":"2002","unstructured":"Detke MJ, et al. Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression. J Psychiatr Res. 2002;36(6):383\u201390.","journal-title":"J Psychiatr Res"},{"issue":"4","key":"946_CR136","doi-asserted-by":"publisher","first-page":"521","DOI":"10.4088\/JCP.v65n0411","volume":"65","author":"M Fava","year":"2004","unstructured":"Fava M, et al. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates? J Clin Psychiatry. 2004;65(4):521\u201330.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"946_CR137","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1097\/j.pain.0000000000001834","volume":"161","author":"HM Gould","year":"2020","unstructured":"Gould HM, et al. A randomized placebo-controlled trial of desipramine, cognitive behavioral therapy, and active placebo therapy for low back pain. Pain. 2020;161(6):1341\u20139.","journal-title":"Pain"},{"issue":"8 Pt 2","key":"946_CR138","first-page":"22","volume":"43","author":"SR Hameroff","year":"1982","unstructured":"Hameroff SR, et al. Doxepin effects on chronic pain, depression and plasma opioids. J Clin Psychiatry. 1982;43(8 Pt 2):22\u20137.","journal-title":"J Clin Psychiatry"},{"issue":"3 Pt 2","key":"946_CR139","first-page":"47","volume":"45","author":"SR Hameroff","year":"1984","unstructured":"Hameroff SR, et al. Doxepin\u2019s effects on chronic pain and depression: a controlled study. J Clin Psychiatry. 1984;45(3 Pt 2):47\u201353.","journal-title":"J Clin Psychiatry"},{"issue":"2 Suppl","key":"946_CR140","first-page":"28","volume":"4","author":"DG Jenkins","year":"1976","unstructured":"Jenkins DG, Ebbutt AF, Evans CD. Tofranil in the treatment of low back pain. J Int Med Res. 1976;4(2 Suppl):28\u201340.","journal-title":"J Int Med Res"},{"issue":"6","key":"946_CR141","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/gps.2386","volume":"25","author":"JF Karp","year":"2010","unstructured":"Karp JF, et al. Duloxetine and care management treatment of older adults with comorbid major depressive disorder and chronic low back pain: results of an open-label pilot study. Int J Geriatr Psychiatry. 2010;25(6):633\u201342.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1\u20132","key":"946_CR142","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pain.2006.10.029","volume":"130","author":"S Khoromi","year":"2007","unstructured":"Khoromi S, et al. Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain. Pain. 2007;130(1\u20132):66\u201375. https:\/\/doi.org\/10.1016\/j.pain.2006.10.029 (Epub 2006 Dec 19).","journal-title":"Pain"},{"issue":"22","key":"946_CR143","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1097\/BRS.0000000000001707","volume":"41","author":"S Konno","year":"2016","unstructured":"Konno S, et al. Randomized, double-blind, placebo-controlled phase III trial of duloxetine monotherapy in Japanese patients with chronic low back pain. Spine (Phila Pa, 2016). 2016;41(22):1709\u201317. https:\/\/doi.org\/10.1097\/BRS.0000000000001707.","journal-title":"Spine (Phila Pa, 2016)"},{"issue":"8","key":"946_CR144","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/pm\/pnz027","volume":"20","author":"SI Konno","year":"2019","unstructured":"Konno SI, et al. An open-label, 52-week, phase III trial of duloxetine in Japanese patients with chronic low back pain. Pain Med. 2019;20(8):1479\u201388. https:\/\/doi.org\/10.1093\/pm\/pnz027.","journal-title":"Pain Med"},{"issue":"20","key":"946_CR145","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1001\/jama.2009.723","volume":"301","author":"K Kroenke","year":"2009","unstructured":"Kroenke K, et al. Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA. 2009;301(20):2099\u2013110.","journal-title":"JAMA"},{"issue":"11","key":"946_CR146","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.4088\/JCP.v68n1105","volume":"68","author":"MR Liebowitz","year":"2007","unstructured":"Liebowitz MR, Yeung PP, Entsuah R. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in adult outpatients with major depressive disorder. J Clin Psychiatry. 2007;68(11):1663\u201372.","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"946_CR147","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1359\/JBMR.040813","volume":"19","author":"D Loldrup","year":"2004","unstructured":"Loldrup D, et al. Clomipramine and mianserin in chronic idiopathic pain syndrome. A placebo controlled study. J Bone Miner Res. 2004;19(11):1766\u201370. https:\/\/doi.org\/10.1359\/JBMR.040813 (Epub 2004 Aug 23).","journal-title":"J Bone Miner Res"},{"key":"946_CR148","doi-asserted-by":"publisher","first-page":"8810178","DOI":"10.1155\/2021\/8810178.eCollection2021","volume":"2021","author":"AMS Mahmoud","year":"2021","unstructured":"Mahmoud AMS, et al. Comparison between two low doses of amitriptyline in the management of chronic neck pain: a randomized, double-blind, comparative study. Pain Res Manag. 2021;2021:8810178. https:\/\/doi.org\/10.1155\/2021\/8810178.eCollection2021.","journal-title":"Pain Res Manag"},{"issue":"5","key":"946_CR149","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jpsychires.2008.07.001","volume":"43","author":"DGS Perahia","year":"2009","unstructured":"Perahia DGS, et al. Switching to duloxetine in selective serotonin reuptake inhibitor non- and partial-responders: effects on painful physical symptoms of depression. J Psychiatr Res. 2009;43(5):512\u20138.","journal-title":"J Psychiatr Res"},{"issue":"5","key":"946_CR150","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/00007632-198307000-00012","volume":"8","author":"H Pheasant","year":"1983","unstructured":"Pheasant H, et al. Amitriptyline and chronic low-back pain. A randomized double-blind crossover study. Spine (Phila Pa, 1983). 1983;8(5):552\u20137. https:\/\/doi.org\/10.1097\/00007632-198307000-00012.","journal-title":"Spine (Phila Pa, 1983)"},{"issue":"6","key":"946_CR151","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1176\/ajp.2007.164.6.900","volume":"164","author":"J Raskin","year":"2007","unstructured":"Raskin J, et al. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. Am J Psychiatry. 2007;164(6):900\u20139.","journal-title":"Am J Psychiatry"},{"issue":"7","key":"946_CR152","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/pme.12456","volume":"15","author":"S Rej","year":"2014","unstructured":"Rej S, Dew MA, Karp JF. Treating concurrent chronic low back pain and depression with low-dose venlafaxine: an initial identification of \u201ceasy-to-use\u201d clinical predictors of early response. Pain Med. 2014;15(7):1154\u201362. https:\/\/doi.org\/10.1111\/pme.12456 (Epub 2014 Jul 4).","journal-title":"Pain Med"},{"issue":"2","key":"946_CR153","first-page":"88","volume":"38","author":"S Schreiber","year":"2001","unstructured":"Schreiber S, et al. A randomized trial of fluoxetine versus amitriptyline in musculo-skeletal pain. Isr J Psychiatry Relat Sci. 2001;38(2):88\u201394.","journal-title":"Isr J Psychiatry Relat Sci"},{"issue":"1","key":"946_CR154","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/ALN.0000000000000902","volume":"124","author":"RP Schukro","year":"2016","unstructured":"Schukro RP, et al. Efficacy of duloxetine in chronic low back pain with a neuropathic component: a randomized, double-blind, placebo-controlled crossover trial. Anesthesiology. 2016;124(1):150\u20138.","journal-title":"Anesthesiology"},{"issue":"13","key":"946_CR155","doi-asserted-by":"publisher","first-page":"E578","DOI":"10.1097\/BRS.0b013e3181d3cef6","volume":"35","author":"V Skljarevski","year":"2010","unstructured":"Skljarevski V, et al. Efficacy and safety of duloxetine in patients with chronic low back pain. Spine. 2010;35(13):E578\u201385. https:\/\/doi.org\/10.1097\/BRS.0b013e3181d3cef6.","journal-title":"Spine"},{"issue":"9","key":"946_CR156","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/j.1468-1331.2009.02648.x","volume":"16","author":"V Skljarevski","year":"2009","unstructured":"Skljarevski V, et al. A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. Eur J Neurol. 2009;16(9):1041\u20138.","journal-title":"Eur J Neurol"},{"issue":"5","key":"946_CR157","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1526-4637.2010.00836.x","volume":"11","author":"V Skljarevski","year":"2010","unstructured":"Skljarevski V, et al. Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study. Pain Med. 2010;11(5):648\u201357. https:\/\/doi.org\/10.1111\/j.1526-4637.2010.00836.x (Epub 2010 Apr 13).","journal-title":"Pain Med"},{"issue":"12","key":"946_CR158","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.jpain.2010.03.002","volume":"11","author":"V Skljarevski","year":"2010","unstructured":"Skljarevski V, et al. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial. J Pain. 2010;11(12):1282\u201390.","journal-title":"J Pain"},{"issue":"11","key":"946_CR159","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1001\/jamainternmed.2018.4222","volume":"178","author":"DM Urquhart","year":"2018","unstructured":"Urquhart DM, et al. Efficacy of low-dose amitriptyline for chronic low back pain: a randomized clinical trial. JAMA Intern Med. 2018;178(11):1474\u201381. https:\/\/doi.org\/10.1001\/jamainternmed.2018.4222.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"946_CR160","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00296-008-0689-2","volume":"29","author":"P Vanelderen","year":"2009","unstructured":"Vanelderen P, et al. Effect of minocycline on lumbar radicular neuropathic pain: a randomized, placebo-controlled, double-blind clinical trial with amitriptyline as a comparator. Rheumatol Int. 2009;29(3):311\u20135. https:\/\/doi.org\/10.1007\/s00296-008-0689-2 (Epub 2008 Sep 2).","journal-title":"Rheumatol Int"},{"issue":"3 Pt 2","key":"946_CR161","first-page":"54","volume":"45","author":"N Ward","year":"1984","unstructured":"Ward N, et al. Antidepressants in concomitant chronic back pain and depression: doxepin and desipramine compared. J Clin Psychiatry. 1984;45(3 Pt 2):54\u20139.","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"946_CR162","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jpain.2005.05.002","volume":"6","author":"J Katz","year":"2005","unstructured":"Katz J, et al. A randomized, placebo-controlled trial of bupropion sustained release in chronic low back pain. J Pain. 2005;6(10):656\u201361.","journal-title":"J Pain"},{"key":"946_CR163","unstructured":"Hirsch M, Birnbaum RJ. Tricyclic and tetracyclic drugs: pharmacology, administration, and side effects. UpToDate. 2020."},{"key":"946_CR164","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.704281","volume":"8","author":"A Calvi","year":"2021","unstructured":"Calvi A, et al. Antidepressant drugs effects on blood pressure. Front Cardiovasc Med. 2021;8: 704281.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"946_CR165","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1136\/emj.18.4.236","volume":"18","author":"GW Kerr","year":"2001","unstructured":"Kerr GW, McGuffie AC, Wilkie S. Tricyclic antidepressant overdose: a review. Emerg Med J. 2001;18(4):236\u201341.","journal-title":"Emerg Med J"},{"issue":"14","key":"946_CR166","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1080\/14656566.2021.1921736","volume":"22","author":"R Brender","year":"2021","unstructured":"Brender R, Mulsant BH, Blumberger DM. An update on antidepressant pharmacotherapy in late-life depression. Expert Opin Pharmacother. 2021;22(14):1909\u201317.","journal-title":"Expert Opin Pharmacother"},{"key":"946_CR167","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/164_2018_164","volume":"250","author":"RC Shelton","year":"2019","unstructured":"Shelton RC. Serotonin and norepinephrine reuptake inhibitors. Handb Exp Pharmacol. 2019;250:145\u201380.","journal-title":"Handb Exp Pharmacol"},{"issue":"10","key":"946_CR168","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1080\/17460441.2018.1511539","volume":"13","author":"JV Pergolizzi JR","year":"2018","unstructured":"Pergolizzi JR JV, et al. Designing safer analgesics: a focus on \u03bc-opioid receptor pathways. Expert Opin Drug Discov. 2018;13(10):965\u201372.","journal-title":"Expert Opin Drug Discov"},{"issue":"7","key":"946_CR169","doi-asserted-by":"publisher","first-page":"514","DOI":"10.7326\/M16-2367","volume":"166","author":"A Qaseem","year":"2017","unstructured":"Qaseem A, et al. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;166(7):514\u201330.","journal-title":"Ann Intern Med"},{"issue":"5","key":"946_CR170","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/17512433.2021.1903316","volume":"14","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, et al. Opioids for chronic low back pain management: a Bayesian network meta-analysis. Expert Rev Clin Pharmacol. 2021;14(5):635\u201341.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"5","key":"946_CR171","volume":"2015","author":"J Santos","year":"2015","unstructured":"Santos J, et al. Tapentadol for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2015;2015(5): CD009923.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"946_CR172","first-page":"73","volume":"24","author":"C Boya","year":"2021","unstructured":"Boya C, et al. Efficacy and safety of opioid analgesics for the management of chronic low back pain: an evidence from Bayesian network meta-analysis. Pain Phys. 2021;24(1):73\u201382.","journal-title":"Pain Phys"},{"issue":"5","key":"946_CR173","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/papr.12199","volume":"15","author":"R Baron","year":"2015","unstructured":"Baron R, et al. Effectiveness and tolerability of a moderate dose of tapentadol prolonged release for managing severe, chronic low back pain with a neuropathic component: an open-label continuation arm of a randomized phase 3b study. Pain Pract. 2015;15(5):471\u201386. https:\/\/doi.org\/10.1111\/papr.12199 (Epub 2014 Apr 18).","journal-title":"Pain Pract"},{"issue":"5","key":"946_CR174","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/papr.12308","volume":"16","author":"R Baron","year":"2016","unstructured":"Baron R, et al. Effectiveness of tapentadol prolonged release (PR) compared with oxycodone\/naloxone PR for the management of severe chronic low back pain with a neuropathic component: a randomized, controlled, open-label, phase 3b\/4 study. Pain Pract. 2016;16(5):580\u201399. https:\/\/doi.org\/10.1111\/papr.12308 (Epub 2015 Jun 12).","journal-title":"Pain Pract"},{"issue":"3","key":"946_CR175","doi-asserted-by":"publisher","first-page":"E237","DOI":"10.36076\/ppj.2013\/16\/E237","volume":"16","author":"D Biondi","year":"2013","unstructured":"Biondi D, et al. Tapentadol immediate release versus oxycodone immediate release for treatment of acute low back pain. Pain Phys. 2013;16(3):E237\u201346.","journal-title":"Pain Phys"},{"issue":"11","key":"946_CR176","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1016\/j.clinthera.2015.08.014","volume":"37","author":"R Buynak","year":"2015","unstructured":"Buynak R, et al. Long-term safety and efficacy of tapentadol extended release following up to 2 years of treatment in patients with moderate to severe, chronic pain: results of an open-label extension trial. Clin Ther. 2015;37(11):2420\u201338. https:\/\/doi.org\/10.1016\/j.clinthera.2015.08.014 (Epub 2015 Oct 1).","journal-title":"Clin Ther"},{"issue":"11","key":"946_CR177","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1517\/14656566.2010.497720","volume":"11","author":"R Buynak","year":"2010","unstructured":"Buynak R, et al. Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study. Expert Opin Pharmacother. 2010;11(11):1787\u2013804. https:\/\/doi.org\/10.1517\/14656566.2010.497720.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"946_CR178","doi-asserted-by":"publisher","first-page":"61","DOI":"10.36076\/ppj.2010\/13\/61","volume":"13","author":"MS Etropolski","year":"2010","unstructured":"Etropolski MS, et al. Dose conversion between tapentadol immediate and extended release for low back pain. Pain Phys. 2010;13(1):61\u201370.","journal-title":"Pain Phys"},{"issue":"3","key":"946_CR179","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s12325-013-0015-6","volume":"30","author":"R G\u00e1lvez","year":"2013","unstructured":"G\u00e1lvez R, et al. Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study. Adv Ther. 2013;30(3):229\u201359. https:\/\/doi.org\/10.1007\/s12325-013-0015-6 (Epub 2013 Mar 7).","journal-title":"Adv Ther"},{"issue":"5","key":"946_CR180","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1185\/03007990902816970","volume":"25","author":"M Hale","year":"2009","unstructured":"Hale M, et al. Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study. Curr Med Res Opin. 2009;25(5):1095\u2013104. https:\/\/doi.org\/10.1185\/03007990902816970.","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"946_CR181","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1185\/03007995.2012.681035","volume":"28","author":"B Lasko","year":"2012","unstructured":"Lasko B, et al. Extended-release tramadol\/paracetamol in moderate-to-severe pain: a randomized, placebo-controlled study in patients with acute low back pain. Curr Med Res Opin. 2012;28(5):847\u201357. https:\/\/doi.org\/10.1185\/03007995.2012.681035 (Epub 2012 Apr 25).","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"946_CR182","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.clinthera.2013.09.017","volume":"35","author":"JH Lee","year":"2013","unstructured":"Lee JH, Lee CS. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of the extended-release tramadol hydrochloride\/acetaminophen fixed-dose combination tablet for the treatment of chronic low back pain. Clin Ther. 2013;35(11):1830\u201340. https:\/\/doi.org\/10.1016\/j.clinthera.2013.09.017 (Epub 2013 Oct 30).","journal-title":"Clin Ther"},{"issue":"9","key":"946_CR183","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1097\/j.pain.0000000000001928","volume":"161","author":"JD Markman","year":"2020","unstructured":"Markman JD, et al. Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety. Pain. 2020;161(9):2068\u201378.","journal-title":"Pain"},{"issue":"1","key":"946_CR184","first-page":"E75","volume":"24","author":"RG Mateos","year":"2021","unstructured":"Mateos RG, et al. Long-term effectiveness and tolerability of pain treatment with tapentadol prolonged release. Pain Phys. 2021;24(1):E75\u201385.","journal-title":"Pain Phys"},{"issue":"9","key":"946_CR185","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/s0149-2918(01)80118-1","volume":"23","author":"WS Mullican","year":"2001","unstructured":"Mullican WS, Lacy JR. Tramadol\/acetaminophen combination tablets and codeine\/acetaminophen combination capsules for the management of chronic pain: a comparative trial. Clin Ther. 2001;23(9):1429\u201345. https:\/\/doi.org\/10.1016\/s0149-2918(01)80118-1.","journal-title":"Clin Ther"},{"issue":"10","key":"946_CR186","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1185\/030079907X233179","volume":"23","author":"MLG Pascual","year":"2007","unstructured":"Pascual MLG, et al. Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain. Curr Med Res Opin. 2007;23(10):2531\u201342.","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"946_CR187","first-page":"2454","volume":"31","author":"PM Peloso","year":"2004","unstructured":"Peloso PM, et al. Analgesic efficacy and safety of tramadol\/acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial. J Rheumatol. 2004;31(12):2454\u201363.","journal-title":"J Rheumatol"},{"issue":"10","key":"946_CR188","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/j.clinthera.2006.10.001","volume":"28","author":"S Perrot","year":"2006","unstructured":"Perrot S, et al. Efficacy and tolerability of paracetamol\/tramadol (325 mg\/37.5 mg) combination treatment compared with tramadol (50 mg) monotherapy in patients with subacute low back pain: a multicenter, randomized, double-blind, parallel-group, 10-day treatment study. Clin Ther. 2006;28(10):1592\u2013606.","journal-title":"Clin Ther"},{"issue":"4","key":"946_CR189","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s00586-014-3229-7","volume":"23","author":"HRS Preuper","year":"2014","unstructured":"Preuper HRS, et al. Do analgesics improve functioning in patients with chronic low back pain? An explorative triple-blinded RCT. Eur Spine J. 2014;23(4):800\u20136.","journal-title":"Eur Spine J"},{"issue":"6","key":"946_CR190","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2165\/00044011-199917060-00001","volume":"17","author":"M Raber","year":"1999","unstructured":"Raber M, et al. Analgesic efficacy and tolerability of tramadol 100mg sustained-release capsules in patients with moderate to severe chronic low back pain. Clin Drug Investig. 1999;17(6):415\u201323.","journal-title":"Clin Drug Investig"},{"issue":"4","key":"946_CR191","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/s0149-2918(03)80071-1","volume":"25","author":"GE Ruoff","year":"2003","unstructured":"Ruoff GE, et al. Tramadol\/acetaminophen combination tablets for the treatment of chronic lower back pain: a multicenter, randomized, double-blind, placebo-controlled outpatient study. Clin Ther. 2003;25(4):1123\u201341. https:\/\/doi.org\/10.1016\/s0149-2918(03)80071-1.","journal-title":"Clin Ther"},{"issue":"3","key":"946_CR192","first-page":"772","volume":"27","author":"TJ Schnitzer","year":"2000","unstructured":"Schnitzer TJ, et al. Efficacy of tramadol in treatment of chronic low back pain. J Rheumatol. 2000;27(3):772\u20138.","journal-title":"J Rheumatol"},{"issue":"3","key":"946_CR193","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3109\/15360288.2013.816406","volume":"27","author":"A Schwittay","year":"2013","unstructured":"Schwittay A, et al. Tapentadol prolonged release for severe chronic pain: results of a noninterventional study involving general practitioners and internists. J Pain Palliat Care Pharmacother. 2013;27(3):225\u201334.","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"3","key":"946_CR194","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2165\/00044011-199714030-00001","volume":"14","author":"J Sorge","year":"1997","unstructured":"Sorge J, Stadler T. Comparison of the analgesic efficacy and tolerability of tramadol 100mg sustained-release tablets and tramadol 50mg capsules for the treatment of chronic low back pain. Clin Drug Investig. 1997;14(3):157\u201364.","journal-title":"Clin Drug Investig"},{"issue":"6","key":"946_CR195","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1185\/03007995.2012.679254","volume":"28","author":"I Steigerwald","year":"2012","unstructured":"Steigerwald I, et al. Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study. Curr Med Res Opin. 2012;28(6):911\u201336. https:\/\/doi.org\/10.1185\/03007995.2012.679254 (Epub 2012 May 9).","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"946_CR196","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00776-014-0674-4","volume":"20","author":"T Tetsunaga","year":"2015","unstructured":"Tetsunaga T, et al. Efficacy of tramadol-acetaminophen tablets in low back pain patients with depression. J Orthop Sci. 2015;20(2):281\u20136. https:\/\/doi.org\/10.1007\/s00776-014-0674-4 (Epub 2015 Feb 3).","journal-title":"J Orthop Sci"},{"issue":"10","key":"946_CR197","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1185\/03007995.2012.726216","volume":"28","author":"MA Uberall","year":"2012","unstructured":"Uberall MA, Mueller-Schwefe GH, Terhaag B. Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study. Curr Med Res Opin. 2012;28(10):1617\u201334. https:\/\/doi.org\/10.1185\/03007995.2012.726216 (Epub 2012 Sep 12).","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"946_CR198","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5055\/jom.2008.0013","volume":"4","author":"GJ Vorsanger","year":"2008","unstructured":"Vorsanger GJ, et al. Extended-release tramadol (tramadol ER) in the treatment of chronic low back pain. J Opioid Manag. 2008;4(2):87\u201397. https:\/\/doi.org\/10.5055\/jom.2008.0013.","journal-title":"J Opioid Manag"},{"issue":"5","key":"946_CR199","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.1533-2500.2010.00397.x","volume":"10","author":"JE Wild","year":"2010","unstructured":"Wild JE, et al. Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis pain. Pain Pract. 2010;10(5):416\u201327. https:\/\/doi.org\/10.1111\/j.1533-2500.2010.00397.x.","journal-title":"Pain Pract"},{"issue":"5","key":"946_CR200","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/papr.12200","volume":"15","author":"R Baron","year":"2015","unstructured":"Baron R, et al. Effectiveness and safety of tapentadol prolonged release (PR) versus a combination of tapentadol PR and pregabalin for the management of severe, chronic low back pain with a neuropathic component: a randomized, double-blind, phase 3b study. Pain Pract. 2015;15(5):455\u201370. https:\/\/doi.org\/10.1111\/papr.12200 (Epub 2014 Apr 17).","journal-title":"Pain Pract"},{"issue":"2","key":"946_CR201","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1365-2710.2004.00624.x","volume":"30","author":"H Malonne","year":"2005","unstructured":"Malonne H, et al. Long-term tolerability of tramadol LP, a new once-daily formulation, in patients with osteoarthritis or low back pain. J Clin Pharm Ther. 2005;30(2):113\u201320. https:\/\/doi.org\/10.1111\/j.1365-2710.2004.00624.x.","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"946_CR202","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/bcp.14401","volume":"87","author":"CD Canecaude","year":"2021","unstructured":"Canecaude CD, et al. Can tramadol really induce hyponatraemia? A pharmacovigilance study. Br J Clin Pharmacol. 2021;87(2):683\u20136.","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"946_CR203","doi-asserted-by":"publisher","first-page":"1382.e1","DOI":"10.1016\/j.amjmed.2018.04.025","volume":"131","author":"S Hassamal","year":"2018","unstructured":"Hassamal S, et al. Tramadol: understanding the risk of serotonin syndrome and seizures. Am J Med. 2018;131(11):1382.e1-1382.e6.","journal-title":"Am J Med"},{"issue":"5","key":"946_CR204","doi-asserted-by":"publisher","first-page":"393","DOI":"10.5055\/jom.2015.0289","volume":"11","author":"DM Biondi","year":"2015","unstructured":"Biondi DM, et al. Tolerability and efficacy of tapentadol extended release in elderly patients \u2265 75 years of age with chronic osteoarthritis knee or low back pain. J Opioid Manag. 2015;11(5):393\u2013403. https:\/\/doi.org\/10.5055\/jom.2015.0289.","journal-title":"J Opioid Manag"},{"issue":"5","key":"946_CR205","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/ejp.1196","volume":"22","author":"J Faria","year":"2018","unstructured":"Faria J, et al. Comparative pharmacology and toxicology of tramadol and tapentadol. Eur J Pain. 2018;22(5):827\u201344.","journal-title":"Eur J Pain"},{"issue":"12","key":"946_CR206","first-page":"5","volume":"40","author":"M Wehrer","year":"2015","unstructured":"Wehrer M. Pain management considerations in cirrhosis. US Pharm. 2015;40(12):5\u201311.","journal-title":"US Pharm"},{"issue":"7","key":"946_CR207","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1001\/jamainternmed.2016.1251","volume":"176","author":"CA Shaheed","year":"2016","unstructured":"Shaheed CA, et al. Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain: a systematic review and meta-analysis. JAMA Intern Med. 2016;176(7):958\u201368.","journal-title":"JAMA Intern Med"},{"issue":"15","key":"946_CR208","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States, 2016. JAMA. 2016;315(15):1624\u201345.","journal-title":"JAMA"},{"issue":"2","key":"946_CR209","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0304-3959(94)00262-D","volume":"62","author":"W Arkinstall","year":"1995","unstructured":"Arkinstall W, et al. Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial. Pain. 1995;62(2):169\u201378.","journal-title":"Pain"},{"issue":"6","key":"946_CR210","doi-asserted-by":"publisher","first-page":"423","DOI":"10.5055\/jom.2014.0239","volume":"10","author":"S Arora","year":"2014","unstructured":"Arora S, et al. A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride\/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain. J Opioid Manag. 2014;10(6):423\u201336.","journal-title":"J Opioid Manag"},{"issue":"8","key":"946_CR211","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.pain.2012.02.028","volume":"153","author":"LF Chu","year":"2012","unstructured":"Chu LF, et al. Analgesic tolerance without demonstrable opioid-induced hyperalgesia: a double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain. Pain. 2012;153(8):1583\u201392. https:\/\/doi.org\/10.1016\/j.pain.2012.02.028 (Epub 2012 Jun 16).","journal-title":"Pain"},{"issue":"2","key":"946_CR212","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1155\/2013\/164609","volume":"18","author":"C Cloutier","year":"2013","unstructured":"Cloutier C, et al. Controlled-release oxycodone and naloxone in the treatment of chronic low back pain: a placebo-controlled, randomized study. Pain Res Manag. 2013;18(2):75\u201382.","journal-title":"Pain Res Manag"},{"issue":"5","key":"946_CR213","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/j.1526-4637.2011.01100.x","volume":"12","author":"N Friedmann","year":"2011","unstructured":"Friedmann N, Klutzaritz V, Webster L. Long-term safety of Remoxy\u00ae (extended-release oxycodone) in patients with moderate to severe chronic osteoarthritis or low back pain. Pain Med. 2011;12(5):755\u201360. https:\/\/doi.org\/10.1111\/j.1526-4637.2011.01100.x (Epub 2011 Apr 11).","journal-title":"Pain Med"},{"issue":"11","key":"946_CR214","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1097\/j.pain.0000000000000670","volume":"157","author":"J Gimbel","year":"2016","unstructured":"Gimbel J, et al. Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomized withdrawal study. Pain. 2016;157(11):2517\u201326. https:\/\/doi.org\/10.1097\/j.pain.0000000000000670.","journal-title":"Pain"},{"issue":"5","key":"946_CR215","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.clinthera.2010.04.018","volume":"32","author":"A Gordon","year":"2010","unstructured":"Gordon A, et al. Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase. Clin Ther. 2010;32(5):844\u201360. https:\/\/doi.org\/10.1016\/j.clinthera.2010.04.018.","journal-title":"Clin Ther"},{"issue":"3","key":"946_CR216","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1155\/2010\/216725","volume":"15","author":"A Gordon","year":"2010","unstructured":"Gordon A, et al. Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain. Pain Res Manag. 2010;15(3):169\u201378. https:\/\/doi.org\/10.1155\/2010\/216725.","journal-title":"Pain Res Manag"},{"issue":"6","key":"946_CR217","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1185\/03007995.2010.484723","volume":"26","author":"M Hale","year":"2010","unstructured":"Hale M, et al. Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain. Curr Med Res Opin. 2010;26(6):1505\u201318. https:\/\/doi.org\/10.1185\/03007995.2010.484723.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"946_CR218","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/00002508-199909000-00004","volume":"15","author":"ME Hale","year":"1999","unstructured":"Hale ME, et al. Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain. Clin J Pain. 1999;15(3):179\u201383.","journal-title":"Clin J Pain"},{"issue":"2","key":"946_CR219","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5055\/jom.2016.0326","volume":"12","author":"ME Hale","year":"2016","unstructured":"Hale ME, Ma Y, Malamut R. Six-month, open-label study of hydrocodone extended release formulated with abuse-deterrence technology: safety, maintenance of analgesia, and abuse potential. J Opioid Manag. 2016;12(2):139\u201347. https:\/\/doi.org\/10.5055\/jom.2016.0326.","journal-title":"J Opioid Manag"},{"issue":"6","key":"946_CR220","doi-asserted-by":"publisher","first-page":"507","DOI":"10.5055\/jom.2015.0304","volume":"11","author":"ME Hale","year":"2015","unstructured":"Hale ME, et al. Efficacy and safety of a hydrocodone extended-release tablet formulated with abuse-deterrence technology in patients with moderate-to-severe chronic low back pain. J Opioid Manag. 2015;11(6):507\u201318. https:\/\/doi.org\/10.5055\/jom.2015.0304.","journal-title":"J Opioid Manag"},{"issue":"12","key":"946_CR221","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1097\/j.pain.0000000000000315","volume":"156","author":"N Katz","year":"2015","unstructured":"Katz N, et al. A phase 3, multicenter, randomized, double-blind, placebo-controlled, safety, tolerability, and efficacy study of Xtampza ER in patients with moderate-to-severe chronic low back pain. Pain. 2015;156(12):2458\u201367.","journal-title":"Pain"},{"issue":"2","key":"946_CR222","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1742-1241.2007.01567.x","volume":"62","author":"K Ma","year":"2008","unstructured":"Ma K, et al. The efficacy of oxycodone for management of acute pain episodes in chronic neck pain patients. Int J Clin Pract. 2008;62(2):241\u20137. https:\/\/doi.org\/10.1111\/j.1742-1241.2007.01567.x (Epub 2007 Dec 6).","journal-title":"Int J Clin Pract"},{"issue":"1","key":"946_CR223","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/pme.12011","volume":"14","author":"F Mitra","year":"2013","unstructured":"Mitra F, et al. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain. Pain Med. 2013;14(1):75\u201383.","journal-title":"Pain Med"},{"issue":"6","key":"946_CR224","first-page":"675","volume":"48","author":"FO M\u00fcller","year":"1998","unstructured":"M\u00fcller FO, et al. Comparison of the efficacy and tolerability of a paracetamol\/codeine fixed-dose combination with tramadol in patients with refractory chronic back pain. Arzneimittelforschung. 1998;48(6):675\u20139.","journal-title":"Arzneimittelforschung"},{"issue":"4","key":"946_CR225","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3349\/ymj.2012.53.4.788","volume":"53","author":"S Ohtori","year":"2012","unstructured":"Ohtori S, et al. Transdermal fentanyl for chronic low back pain. Yonsei Med J. 2012;53(4):788\u201393. https:\/\/doi.org\/10.3349\/ymj.2012.53.4.788.","journal-title":"Yonsei Med J"},{"issue":"1","key":"946_CR226","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1185\/030079906X162818","volume":"23","author":"RK Portenoy","year":"2007","unstructured":"Portenoy RK, et al. Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study. Curr Med Res Opin. 2007;23(1):223\u201333.","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"946_CR227","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5055\/jom.2006.0048","volume":"2","author":"RL Rauck","year":"2006","unstructured":"Rauck RL, et al. A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial. J Opioid Manag. 2006;2(6):325\u20138.","journal-title":"J Opioid Manag"},{"issue":"3","key":"946_CR228","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5055\/jom.2006.0025","volume":"2","author":"RL Rauck","year":"2006","unstructured":"Rauck RL, et al. The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain. J Opioid Manag. 2006;2(3):155\u201366. https:\/\/doi.org\/10.5055\/jom.2006.0025.","journal-title":"J Opioid Manag"},{"issue":"9","key":"946_CR229","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1097\/j.pain.0000000000000230","volume":"156","author":"RL Rauck","year":"2015","unstructured":"Rauck RL, et al. A randomized double-blind, placebo-controlled efficacy and safety study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) for moderate-to-severe chronic low back pain treatment. Pain. 2015;156(9):1660\u20139. https:\/\/doi.org\/10.1097\/j.pain.0000000000000230.","journal-title":"Pain"},{"issue":"6","key":"946_CR230","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/pme.12377","volume":"15","author":"RL Rauck","year":"2014","unstructured":"Rauck RL, et al. Single-entity hydrocodone extended-release capsules in opioid-tolerant subjects with moderate-to-severe chronic low back pain: a randomized double-blind, placebo-controlled study. Pain Med. 2014;15(6):975\u201385. https:\/\/doi.org\/10.1111\/pme.12377 (Epub 2014 Feb 12).","journal-title":"Pain Med"},{"issue":"1","key":"946_CR231","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00325481.2016.1128307","volume":"128","author":"RL Rauck","year":"2016","unstructured":"Rauck RL, et al. Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back pain. Postgrad Med. 2016;128(1):1\u201311. https:\/\/doi.org\/10.1080\/00325481.2016.1128307 (Epub 2015 Dec 22).","journal-title":"Postgrad Med"},{"issue":"4","key":"946_CR232","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s0885-3924(99)00079-2","volume":"18","author":"RT Salzman","year":"1999","unstructured":"Salzman RT, et al. Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control? J Pain Symptom Manag. 1999;18(4):271\u20139. https:\/\/doi.org\/10.1016\/s0885-3924(99)00079-2.","journal-title":"J Pain Symptom Manag"},{"issue":"4","key":"946_CR233","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/s0885-3924(97)00183-8","volume":"14","author":"RK Simpson Jr","year":"1997","unstructured":"Simpson RK Jr, et al. Transdermal fentanyl as treatment for chronic low back pain. J Pain Symptom Manag. 1997;14(4):218\u201324. https:\/\/doi.org\/10.1016\/s0885-3924(97)00183-8.","journal-title":"J Pain Symptom Manag"},{"issue":"11","key":"946_CR234","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.jpain.2011.06.003","volume":"12","author":"D Steiner","year":"2011","unstructured":"Steiner D, et al. Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: a randomized, double-blind study. J Pain. 2011;12(11):1163\u201373.","journal-title":"J Pain"},{"issue":"6","key":"946_CR235","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jpainsymman.2011.04.006","volume":"42","author":"DJ Steiner","year":"2011","unstructured":"Steiner DJ, et al. Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-na\u00efve patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study. J Pain Symptom Manag. 2011;42(6):903\u201317. https:\/\/doi.org\/10.1016\/j.jpainsymman.2011.04.006 (Epub 2011 Sep 25).","journal-title":"J Pain Symptom Manag"},{"issue":"12","key":"946_CR236","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.jpain.2008.06.014","volume":"9","author":"D Vondrackova","year":"2008","unstructured":"Vondrackova D, et al. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain. J Pain. 2008;9(12):1144\u201354.","journal-title":"J Pain"},{"issue":"5","key":"946_CR237","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1185\/030079907X182040","volume":"23","author":"M Wallace","year":"2007","unstructured":"Wallace M, et al. Efficacy and safety evaluation of once-daily OROS hydromorphone in patients with chronic low back pain: a pilot open-label study (DO-127). Curr Med Res Opin. 2007;23(5):981\u20139.","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"946_CR238","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/j.1526-4637.2010.00956.x","volume":"11","author":"M Wallace","year":"2010","unstructured":"Wallace M, Thipphawong J. Open-label study on the long-term efficacy, safety, and impact on quality of life of OROS hydromorphone ER in patients with chronic low back pain. Pain Med. 2010;11(10):1477\u201388. https:\/\/doi.org\/10.1111\/j.1526-4637.2010.00956.x.","journal-title":"Pain Med"},{"issue":"12","key":"946_CR239","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jpain.2006.05.005","volume":"7","author":"LR Webster","year":"2006","unstructured":"Webster LR, et al. Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain. J Pain. 2006;7(12):937\u201346. https:\/\/doi.org\/10.1016\/j.jpain.2006.05.005.","journal-title":"J Pain"},{"issue":"11","key":"946_CR240","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1517\/14656566.2015.1060221","volume":"16","author":"W Wen","year":"2015","unstructured":"Wen W, et al. A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with uncontrolled moderate to severe chronic low back pain. Expert Opin Pharmacother. 2015;16(11):1593\u2013606.","journal-title":"Expert Opin Pharmacother"},{"issue":"4B","key":"946_CR241","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/0002-9343(86)90082-3","volume":"80","author":"DH Yoon","year":"1986","unstructured":"Yoon DH, et al. Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain. Am J Med. 1986;80(4B):58\u201363. https:\/\/doi.org\/10.1016\/0002-9343(86)90082-3.","journal-title":"Am J Med"},{"issue":"8","key":"946_CR242","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s40266-017-0473-7","volume":"34","author":"EA Kopecky","year":"2017","unstructured":"Kopecky EA, et al. Tolerability, safety, and effectiveness of oxycodone DETERx in elderly patients \u226565 years of age with chronic low back pain: a randomized controlled trial. Drugs Aging. 2017;34(8):603\u201313. https:\/\/doi.org\/10.1007\/s40266-017-0473-7.","journal-title":"Drugs Aging"},{"issue":"1","key":"946_CR243","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2019-000523","volume":"6","author":"F Chung","year":"2019","unstructured":"Chung F, et al. Predictive factors for sleep apnoea in patients on opioids for chronic pain. BMJ Open Respir Res. 2019;6(1): e000523.","journal-title":"BMJ Open Respir Res"},{"issue":"Suppl 1","key":"946_CR244","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1111\/pme.12915","volume":"16","author":"A Chen","year":"2015","unstructured":"Chen A, Ashburn MA. Cardiac effects of opioid therapy. Pain Med. 2015;16(Suppl 1):S27\u201331.","journal-title":"Pain Med"},{"issue":"2","key":"946_CR245","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.0217","volume":"1","author":"T Gomes","year":"2018","unstructured":"Gomes T, et al. The burden of opioid-related mortality in the United States. JAMA Netw Open. 2018;1(2): e180217.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"946_CR246","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ejpain.2004.07.011","volume":"9","author":"OHG Wilder-Smith","year":"2005","unstructured":"Wilder-Smith OHG. Opioid use in the elderly. Eur J Pain. 2005;9(2):137\u201340.","journal-title":"Eur J Pain"},{"issue":"1","key":"946_CR247","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jpain.2005.08.001","volume":"7","author":"LF Chu","year":"2006","unstructured":"Chu LF, Clark DJ, Angst MS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain. 2006;7(1):43\u20138.","journal-title":"J Pain"},{"issue":"8","key":"946_CR248","first-page":"34","volume":"39","author":"S Gelot","year":"2014","unstructured":"Gelot S, Nakhla E. Opioid dosing in renal and hepatic impairment. US Pharm. 2014;39(8):34\u20138.","journal-title":"US Pharm"},{"issue":"S1","key":"946_CR249","first-page":"S27","volume":"24","author":"L Manchikanti","year":"2021","unstructured":"Manchikanti L, et al. Epidural interventions in the management of chronic spinal pain: American Society of Interventional Pain Physicians (ASIPP) comprehensive evidence-based guidelines. Pain Phys. 2021;24(S1):S27\u2013208.","journal-title":"Pain Phys"},{"issue":"6","key":"946_CR250","doi-asserted-by":"publisher","first-page":"425","DOI":"10.36076\/ppj.2021.24.425","volume":"24","author":"L Manchikanti","year":"2021","unstructured":"Manchikanti L, et al. A comparative systematic review and meta-analysis of 3 routes of administration of epidural injections in lumbar disc herniation. Pain Phys. 2021;24(6):425\u201340.","journal-title":"Pain Phys"},{"issue":"11","key":"946_CR251","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1007\/s00586-021-06854-9","volume":"30","author":"EJA Verheijen","year":"2021","unstructured":"Verheijen EJA, et al. Epidural steroid compared to placebo injection in sciatica: a systematic review and meta-analysis. Eur Spine J. 2021;30(11):3255\u201364.","journal-title":"Eur Spine J"},{"issue":"4S","key":"946_CR252","first-page":"S239","volume":"23","author":"NN Knezevic","year":"2020","unstructured":"Knezevic NN, et al. Lack of superiority of epidural injections with lidocaine with steroids compared to without steroids in spinal pain: a systematic review and meta-analysis. Pain Phys. 2020;23(4S):S239\u201370.","journal-title":"Pain Phys"},{"issue":"5","key":"946_CR253","doi-asserted-by":"publisher","first-page":"449","DOI":"10.36076\/ppj.2018.5.449","volume":"21","author":"JH Lee","year":"2018","unstructured":"Lee JH, et al. Comparison of clinical efficacy of epidural injection with or without steroid in lumbosacral disc herniation: a systematic review and meta-analysis. Pain Phys. 2018;21(5):449\u201368.","journal-title":"Pain Phys"},{"issue":"5","key":"946_CR254","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1097\/ALN.0000000000000614","volume":"122","author":"JP Rathmell","year":"2015","unstructured":"Rathmell JP, et al. Safeguards to prevent neurologic complications after epidural steroid injections: consensus opinions from a multidisciplinary working group and national organizations. Anesthesiology. 2015;122(5):974\u201384.","journal-title":"Anesthesiology"},{"issue":"6","key":"946_CR255","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/pm\/pnaa087","volume":"21","author":"BJ Schneider","year":"2020","unstructured":"Schneider BJ, et al. Anticoagulants for lumbar epidural steroid injections. Pain Med. 2020;21(6):1294\u20135.","journal-title":"Pain Med"},{"issue":"8","key":"946_CR256","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jpain.2011.04.012","volume":"12","author":"R Chou","year":"2011","unstructured":"Chou R, et al. Guideline warfare over interventional therapies for low back pain: can we raise the level of discourse? J Pain. 2011;12(8):833\u20139.","journal-title":"J Pain"},{"issue":"6","key":"946_CR257","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/rapm-2019-101243","volume":"45","author":"SP Cohen","year":"2020","unstructured":"Cohen SP, et al. Consensus practice guidelines on interventions for lumbar facet joint pain from a multispecialty, international working group. Reg Anesth Pain Med. 2020;45(6):424\u201367.","journal-title":"Reg Anesth Pain Med"},{"key":"946_CR258","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.2147\/JPR.S325665","volume":"14","author":"DW Lee","year":"2021","unstructured":"Lee DW, et al. Latest evidence-based application for radiofrequency neurotomy (LEARN): best practice guidelines from the American Society of Pain and Neuroscience (ASPN). J Pain Res. 2021;14:2807\u201331.","journal-title":"J Pain Res"},{"issue":"1","key":"946_CR259","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1526-4637.2008.00526.x","volume":"10","author":"NA Scott","year":"2009","unstructured":"Scott NA, et al. Trigger point injections for chronic non-malignant musculoskeletal pain: a systematic review. Pain Med. 2009;10(1):54\u201369.","journal-title":"Pain Med"},{"issue":"8","key":"946_CR260","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1177\/2192568220962440","volume":"11","author":"J-F Huang","year":"2021","unstructured":"Huang J-F, et al. Can acupuncture improve chronic spinal pain? A systematic review and meta-analysis. Glob Spine J. 2021;11(8):1248\u201365.","journal-title":"Glob Spine J"},{"key":"946_CR261","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2147\/JPR.S83574","volume":"9","author":"T Paolucci","year":"2016","unstructured":"Paolucci T, Saraceni VM, Piccinini G. Management of chronic pain in osteoporosis: challenges and solutions. J Pain Res. 2016;9:177\u201386.","journal-title":"J Pain Res"},{"issue":"1","key":"946_CR262","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00198-011-1676-0","volume":"23","author":"JA Knopp-Sihota","year":"2012","unstructured":"Knopp-Sihota JA, et al. Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: a systematic review and meta-analysis. Osteoporos Int. 2012;23(1):17\u201338.","journal-title":"Osteoporos Int"},{"issue":"2","key":"946_CR263","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/neuros\/nyz573","volume":"87","author":"TE Kim","year":"2020","unstructured":"Kim TE, et al. Cannabinoids in the treatment of back pain. Neurosurgery. 2020;87(2):166\u201375.","journal-title":"Neurosurgery"},{"issue":"10","key":"946_CR264","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s40266-021-00882-2","volume":"38","author":"S Pisani","year":"2021","unstructured":"Pisani S, et al. Safety and tolerability of natural and synthetic cannabinoids in older adults: a systematic review and meta-analysis of open-label trials and observational studies. Drugs Aging. 2021;38(10):887\u2013910.","journal-title":"Drugs Aging"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-022-00946-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-022-00946-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-022-00946-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T19:34:14Z","timestamp":1700768054000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-022-00946-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":264,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["946"],"URL":"https:\/\/doi.org\/10.1007\/s40266-022-00946-x","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]},"assertion":[{"value":"5 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There was no funding or financial support for this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no conflicts of interest related to the paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent"}},{"value":"Study concept and design: all authors; study supervision: MP; acquisition of data: JF; analysis and interpretation of data: JF and MP; critical revision of manuscript for intellectual content: all authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}}]}}